We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Supreme Court Sides With Generic-Drug Makers in Ruling
Supreme Court Sides With Generic-Drug Makers in Ruling
April 20, 2012
The Supreme Court has unanimously ruled that generic-drug maker Caraco Pharmaceuticals can challenge Novo Nordisk’s “overbroad” patent listing for diabetes drug Prandin, reversing and remanding a lower court’s decision that critics called an existential threat to the generic industry.